An argument among clinical researchers, treatment access activists in both the developed and the developing world, and academic bioethicists has been raging for more than a decade. It is concerned ...
No takes yet. Share an insight, caveat, or question.
Udo Schüklenk (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: